Pharming Group (NASDAQ: PHAR) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT PHARMING GROUP

Pharming Group (NASDAQ: PHAR)
Listen to this Section


$12.36
+0.1150 ( +0.94% ) 8.9K

Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.

Market Data


Open $12.36
Previous Close $12.24
Volume 8.9K
Market Cap $864.45M
Day Range $12.24 - $12.66
52 Week Range $9.54 - $21.34
Shares Outstanding 70.63M
Change % +0.94%
Net Change ▲ 0.1150
Insider Ownership N/A
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2020
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
6-k Form 6-K 3 Nov 06, 2025
6-k Form 6-K 3 Oct 22, 2025
6-k Form 6-K 3 Oct 06, 2025
6-k Form 6-K 3 Oct 01, 2025
6-k Form 6-K 3 Sep 10, 2025
6-k Form 6-K 3 Sep 02, 2025
6-k Form 6-K 3 Jul 31, 2025
6-k Form 6-K 3 Jun 24, 2025
6-k Form 6-K 3 Jun 11, 2025

Latest News


× Before browsing our site, please accept our cookies policy